产品描述: | Sertindole (Lu 23-174) is an orally active 5-HT2A, 5-HT2C, dopamine D2, and αl-adrenergic receptors antagonist. Sertindole shows antipsychotic activity and anti-proliferative activity to multiple cancer cells. |
靶点: |
5-HT2A Receptor;5-HT2C Receptor;DopamineReceptor;5-HTReceptor;AdrenergicReceptor;Autophagy |
体内研究: |
Sertindole (oral gavage; 10 mg/kg; once daily; 12 d) shows anti-tumor activity in vivo |
参考文献: |
1. David Murdoch, et al. Sertindole : a review of its use in schizophrenia. CNS Drugs. 2006;20(3):233-55. 2. Wei Zhang, et al. Antiproliferative activities of the second-generation antipsychotic drug sertindole against breast cancers with a potential application for treatment of breast-to-brain metastases. Sci Rep. 2018 Oct 25;8(1):15753. 3. Mario F Juruena, et al. Sertindole in the management of schizophrenia. J Cent Nerv Syst Dis. 2011 May 17;3:75-85. |
溶解性: |
DMSO : 25 mg/mL (56.70 mM; Need ultrasonic) |
保存条件: |
-20℃ |
配置溶液浓度参考: |
|
1mg |
5mg |
10mg |
1 mM |
2.268 ml |
11.339 ml |
22.679 ml |
5 mM |
0.454 ml |
2.268 ml |
4.536 ml |
10 mM |
0.227 ml |
1.134 ml |
2.268 ml |
50 mM |
0.045 ml |
0.227 ml |
0.454 ml |
|
注意: |
部分产品我司仅能提供部分信息,我司不保证所提供信息的权威性,仅供客户参考交流研究之用。 |